[go: up one dir, main page]

MX9603314A - Composiciones que contienen nebivolol micronizado. - Google Patents

Composiciones que contienen nebivolol micronizado.

Info

Publication number
MX9603314A
MX9603314A MX9603314A MX9603314A MX9603314A MX 9603314 A MX9603314 A MX 9603314A MX 9603314 A MX9603314 A MX 9603314A MX 9603314 A MX9603314 A MX 9603314A MX 9603314 A MX9603314 A MX 9603314A
Authority
MX
Mexico
Prior art keywords
compositions containing
containing micronized
micronized nebivolol
nebivolol
ways
Prior art date
Application number
MX9603314A
Other languages
English (en)
Inventor
Eugeen Marie Jozef Jans
Guido Franciscus Smans
Paul Marie Victor Gilis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22731545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9603314(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MX9603314A publication Critical patent/MX9603314A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Dental Preparations (AREA)

Abstract

La presente invencion se refiere a composiciones farmacéuticas que contienen como ingrediente activo al nebivolol micronizado de formula (I) (Ver Formula) y a las formas de preparar dichas composiciones.
MX9603314A 1994-02-17 1995-02-10 Composiciones que contienen nebivolol micronizado. MX9603314A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19798894A 1994-02-17 1994-02-17
PCT/EP1995/000489 WO1995022325A1 (en) 1994-02-17 1995-02-10 Compositions containing micronized nebivolol

Publications (1)

Publication Number Publication Date
MX9603314A true MX9603314A (es) 1997-02-28

Family

ID=22731545

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9603314A MX9603314A (es) 1994-02-17 1995-02-10 Composiciones que contienen nebivolol micronizado.

Country Status (30)

Country Link
US (1) US5759580A (es)
EP (1) EP0744946B1 (es)
JP (1) JP3810079B2 (es)
KR (1) KR100361636B1 (es)
CN (1) CN1112921C (es)
AT (1) ATE212547T1 (es)
AU (1) AU688860B2 (es)
BR (1) BR9506828A (es)
CA (1) CA2182582C (es)
CY (1) CY2329B1 (es)
CZ (1) CZ290844B6 (es)
DE (1) DE69525241T2 (es)
DK (1) DK0744946T3 (es)
ES (1) ES2171533T3 (es)
FI (1) FI117888B (es)
HU (1) HU221848B1 (es)
IL (1) IL112659A (es)
MX (1) MX9603314A (es)
MY (1) MY115339A (es)
NO (1) NO314712B1 (es)
NZ (1) NZ279822A (es)
PL (1) PL178505B1 (es)
PT (1) PT744946E (es)
RU (1) RU2137473C1 (es)
SG (1) SG47487A1 (es)
SI (1) SI0744946T1 (es)
SK (1) SK283250B6 (es)
TW (1) TW355683B (es)
WO (1) WO1995022325A1 (es)
ZA (1) ZA951294B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2176354T3 (es) * 1994-12-28 2002-12-01 Janssen Pharmaceutica Nv Uso de nebivolol como agente anti-aterogenico.
BR9612291A (pt) 1995-12-27 1999-07-13 Janssen Pharmaceutica Nv Forma de dosagem sólida bioadesiva
DE19637082A1 (de) 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
AU3176097A (en) * 1997-06-13 1998-12-30 Medinova Medical Consulting Gmbh Drug targeting system, method of its preparation and its use
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
AR016827A1 (es) * 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
US20030152636A1 (en) * 2000-02-23 2003-08-14 Nanopharm Ag Method of treating cancer
US6531158B1 (en) * 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
ATE437637T1 (de) 2001-05-02 2009-08-15 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
RU2214234C1 (ru) * 2002-11-25 2003-10-20 Нестерук Владимир Викторович ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ СВОЙСТВАМИ КАРДИОСЕЛЕКТИВНОГО β1-АДРЕНОБЛОКАТОРА
RU2286779C2 (ru) * 2003-02-06 2006-11-10 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственная форма, обладающая диуретическим и антигипертензивным действием, и способ ее изготовления
US7803838B2 (en) * 2004-06-04 2010-09-28 Forest Laboratories Holdings Limited Compositions comprising nebivolol
US8604222B2 (en) * 2004-07-30 2013-12-10 Forest Laboratories Holdings Limited Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
PL1776354T3 (pl) * 2004-08-11 2010-09-30 Hetero Drugs Ltd Nowy sposób wytwarzania związków pośrednich nebiwololu
US7344907B2 (en) * 2004-11-19 2008-03-18 International Business Machines Corporation Apparatus and methods for encapsulating microelectromechanical (MEM) devices on a wafer scale
NZ560386A (en) * 2005-01-31 2009-12-24 Mylan Lab Inc Pharmaceutical composition comprising hydroxylated nebivolol
EP1850842A1 (de) * 2005-02-11 2007-11-07 Stada Arzneimittel Ag Pharmazeutische zusammensetzungen nebivolo und ein hydrophiles polymer
US7560575B2 (en) 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1803716B1 (en) * 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
WO2007083318A1 (en) * 2006-01-18 2007-07-26 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
EP1839658A1 (en) * 2006-03-30 2007-10-03 Hexal A/S Pharmaceutical composition comprising micronized nebivolol
DE102006036579A1 (de) * 2006-08-04 2008-02-07 Alfred E. Tiefenbacher Gmbh & Co.Kg Pharmazeutische Zusammensetzung
EP1886674B1 (de) * 2006-08-04 2010-03-31 Alfred, E. Tiefenbacher Gmbh & Co. Kg Pharmazeutische Zusammensetzung enthaltend Nebivolol
UA97813C2 (uk) * 2006-12-05 2012-03-26 Янссен Фармацевтика Н.В. Фумаратна сіль (альфа s, бета r)-6-бром-альфа-[2-(диметиламіно)етил]-2-метоксі-альфа-1-нафталеніл-бета-феніл-3-хінолінетанолу
CA2675538C (en) * 2007-01-22 2017-02-28 Genpharm Ulc Oral pharmaceutical compositions comprising unmicronized nebivolol or a nebivolol analogue as active ingredient, and a decreased ratio of wetting agent to active ingredient
WO2009004649A2 (en) * 2007-05-21 2009-01-08 Sun Pharmaceutical Industries Limited Enteric coated pharmaceutical compositions
CA2637979A1 (en) * 2007-07-26 2009-01-26 Mylan Laboratories, Inc. Treatment of cardiovascular disease in mexican americans using nebivolol
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
US20090181975A1 (en) * 2008-01-15 2009-07-16 Forest Laboratories Holdings Limited Nebivolol in the treatment of sexual dysfunction
EP2163551B1 (en) 2008-09-08 2011-11-16 Cadila Pharmaceuticals Ltd. An improved process for the preparation of nebivolol hydrochloride
IT1395354B1 (it) 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
IT1397962B1 (it) 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
KR20110130872A (ko) * 2010-05-28 2011-12-06 현대약품 주식회사 결정형 염산 네비볼롤을 포함하는 약학 조성물 및 제조방법
US20120003304A1 (en) * 2010-07-02 2012-01-05 Fmc Corporation Solid Forms
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法
KR20190140011A (ko) * 2017-04-28 2019-12-18 아사나 바이오사이언시스 엘엘씨 아토피성 피부염을 치료하고, 활성 약학적 성분의 안정성을 개선하기 위한 제형물, 방법, 키트, 및 투여형
US20220016025A1 (en) * 2020-07-08 2022-01-20 Vinayak Dinesh DENDUKURI Formulations of nebivolol

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60107106A (ja) * 1983-11-15 1985-06-12 Mitsubishi Electric Corp 曲線補間装置
CA1337429C (en) * 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol
CA1337432C (en) * 1988-03-23 1995-10-24 Raymond M. Xhonneux Method of lowering the blood pressure
JPH02264744A (ja) * 1989-04-04 1990-10-29 Kyowa Hakko Kogyo Co Ltd 光学活性なｐ―フルオロフェノキシ誘導体およびその製造法

Also Published As

Publication number Publication date
IL112659A (en) 1999-06-20
CA2182582C (en) 2005-03-29
FI117888B (fi) 2007-04-13
MY115339A (en) 2003-05-31
CA2182582A1 (en) 1995-08-24
KR100361636B1 (ko) 2003-02-11
BR9506828A (pt) 1997-09-30
PL315973A1 (en) 1996-12-23
RU2137473C1 (ru) 1999-09-20
CZ290844B6 (cs) 2002-10-16
ATE212547T1 (de) 2002-02-15
NO963439L (no) 1996-08-16
HU9602272D0 (en) 1996-10-28
IL112659A0 (en) 1995-05-26
SI0744946T1 (en) 2002-06-30
AU688860B2 (en) 1998-03-19
WO1995022325A1 (en) 1995-08-24
PT744946E (pt) 2002-07-31
EP0744946B1 (en) 2002-01-30
ZA951294B (en) 1996-08-16
NZ279822A (en) 1997-04-24
NO314712B1 (no) 2003-05-12
ES2171533T3 (es) 2002-09-16
US5759580A (en) 1998-06-02
FI963227A0 (fi) 1996-08-16
CY2329B1 (en) 2004-02-06
SK105896A3 (en) 1997-05-07
CN1140991A (zh) 1997-01-22
TW355683B (en) 1999-04-11
SK283250B6 (sk) 2003-04-01
HUT75332A (en) 1997-05-28
JPH09508913A (ja) 1997-09-09
CZ234696A3 (en) 1996-11-13
EP0744946A1 (en) 1996-12-04
FI963227L (fi) 1996-08-16
DK0744946T3 (da) 2002-05-06
DE69525241D1 (de) 2002-03-14
PL178505B1 (pl) 2000-05-31
JP3810079B2 (ja) 2006-08-16
CN1112921C (zh) 2003-07-02
SG47487A1 (en) 1998-04-17
DE69525241T2 (de) 2002-08-29
AU1706895A (en) 1995-09-04
HU221848B1 (hu) 2003-02-28

Similar Documents

Publication Publication Date Title
MY115339A (en) Compositions containing micronized nebivolol
GEP20002211B (en) Taxoids, Preparation Thereof, Pharmaceutical Compositions Containing Same
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
AU6542986A (en) Pyridyl-methylthio substituted benzimidazoles
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
MY101784A (en) Novel pharmacological compounds
MY116845A (en) New 19-nor-pregnene derivatives
IL107870A0 (en) Pharmaceutical compositions having antidepressant activity comprising pramipexol
BG106155A (en) Novel derivatives and analogues of galanthamin
ES8207169A1 (es) Un procedimiento para la preparacion de nuevos derivados de piperazinilquinazolina y de homopiperazinilquinazolina hi- pertensora con acticidad.
ZA952771B (en) Novel compound
BG103260A (en) The application of 1-hydroxy-2-pyridons for the treatment of seborrheic dermatitis
AU3580995A (en) Derivatives of carbohydrates and compositions containing them
GR3017348T3 (en) Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
NO973401L (no) Kortikosteroidinneholdende sammensetninger og fremstilling derav
LT96094A (en) The active ingredient of pharmaceutical composition for treating constipation
MY106235A (en) New 2 - carbonyl substituted n, n'' -di (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.
AU4146000A (en) Remedies for glomerulosclerosis
BG106093A (en) 14beta-h-sterols, pharmaceutical compositions comprising them and the use of these derivatives for the preparation of meiosis regulating medicaments
JO1711B1 (en) Therapeutic agents
JO1531B1 (en) New near-compounds
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)